Literature DB >> 30126038

Impact of dental cement on the peri-implant biofilm-microbial comparison of two different cements in an in vivo observational study.

Michael Korsch1,2,3, Silke-Mareike Marten4, Winfried Walther1, Marius Vital5, Dietmar H Pieper5, Andreas Dötsch6,4.   

Abstract

BACKGROUND: The type of cement used in cemented fixed implant-supported restorations influences formation of undetected excess cement and composition of the peri-implant biofilm. Excess cement and dysbiosis of the biofilm involve the risk of peri-implant inflammation.
PURPOSE: The aim of the study was to investigate the impact of two different cements on the peri-implant biofilm and inflammation.
MATERIALS AND METHODS: In an observational study, the suprastructures of 34 patients with cemented fixed implant-supported restorations were revised. In 20 patients, a methacrylate cement (Premier Implant cement [PIC]) and in 14 patients, a zinc oxide eugenol cement (Temp Bond [TB]) were used. After revision, TB was used for recementation. During revision and follow-up after 1 year, microbial samples were obtained.
RESULTS: Excess cement was found in 12 (60%) of the 20 patients with PIC. Suppuration was observed in two (25%) implants with PIC without excess cement (PIC-) and in all 12 (100%) implants with PIC and excess cement (PIC+). Implants cemented with TB had neither excess cement nor suppuration. The taxonomic analysis of the microbial samples revealed an accumulation of periodontal pathogens in the PIC patients independent of the presence of excess cement. Significantly, fewer oral pathogens occurred in patients with TB compared to patients with PIC. TB was used in all cases (PIC and TB) for recementation. In the follow-up check, suppuration was not found around any of the implants with PIC-, only around one implant with PIC+ and around one implant with TB. Bacterial species associated with severe periodontal infections that were abundant in PIC- and PIC+ samples before the revision were reduced after 1 year to levels found in the TB samples.
CONCLUSIONS: The revision and recementation with TB had a positive effect on the peri-implant biofilm in cases with PIC. The cementation of suprastructures on implants with TB is an alternative method to be considered.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  biofilms; dental cements; implant; in vivo observational study; molecular biological analysis

Mesh:

Substances:

Year:  2018        PMID: 30126038     DOI: 10.1111/cid.12650

Source DB:  PubMed          Journal:  Clin Implant Dent Relat Res        ISSN: 1523-0899            Impact factor:   3.932


  6 in total

1.  In vitro validation of Digital Image Analysis Sequence (DIAS) for the assessment of the marginal fit of cement-retained implant-supported experimental crowns.

Authors:  Aristeidis A Villias; Stefanos G Kourtis; Hercules C Karkazis; Gregory L Polyzois
Journal:  Int J Implant Dent       Date:  2021-02-15

2.  Microbiological findings in early and late implant loss: an observational clinical case-controlled study.

Authors:  Michael Korsch; Silke-Mareike Marten; Dominic Stoll; Christopher Prechtl; Andreas Dötsch
Journal:  BMC Oral Health       Date:  2021-03-11       Impact factor: 2.757

3.  Esthetic Evaluation and Acceptability of Different Hole Designs on Implant Crowns from the Perspective of Patients and Dentists in China.

Authors:  Cai Wen; Rong Jiang; Zhiqiang Zhang; Bo Lei; Yingquan Zhong; Huangjun Zhou
Journal:  Patient Prefer Adherence       Date:  2022-02-17       Impact factor: 2.711

4.  Titanium Base Abutments in Implant Prosthodontics: A Literature Review.

Authors:  Ahmad M Al-Thobity
Journal:  Eur J Dent       Date:  2021-11-18

Review 5.  Zinc Adequacy Is Essential for the Maintenance of Optimal Oral Health.

Authors:  Anne Marie Uwitonze; Nkemcho Ojeh; Julienne Murererehe; Azeddine Atfi; Mohammed S Razzaque
Journal:  Nutrients       Date:  2020-03-30       Impact factor: 5.717

Review 6.  Bioadhesion in the oral cavity and approaches for biofilm management by surface modifications.

Authors:  Torsten Sterzenbach; Ralf Helbig; Christian Hannig; Matthias Hannig
Journal:  Clin Oral Investig       Date:  2020-10-27       Impact factor: 3.573

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.